Cargando…

The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

OBJECTIVE: To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Premranjan P., Abbott, J. Dawn, Lombardero, Manuel S., Sutton-Tyrrell, Kim, Woodhead, Gail, Venkitachalam, Lakshmi, Tsapatsaris, Nicholas P., Piemonte, Thomas C., Lago, Rodrigo M., Rutter, Martin K., Nesto, Richard W.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024368/
https://www.ncbi.nlm.nih.gov/pubmed/21270200
http://dx.doi.org/10.2337/dc10-1734
_version_ 1782196774066192384
author Singh, Premranjan P.
Abbott, J. Dawn
Lombardero, Manuel S.
Sutton-Tyrrell, Kim
Woodhead, Gail
Venkitachalam, Lakshmi
Tsapatsaris, Nicholas P.
Piemonte, Thomas C.
Lago, Rodrigo M.
Rutter, Martin K.
Nesto, Richard W.
author_facet Singh, Premranjan P.
Abbott, J. Dawn
Lombardero, Manuel S.
Sutton-Tyrrell, Kim
Woodhead, Gail
Venkitachalam, Lakshmi
Tsapatsaris, Nicholas P.
Piemonte, Thomas C.
Lago, Rodrigo M.
Rutter, Martin K.
Nesto, Richard W.
author_sort Singh, Premranjan P.
collection PubMed
description OBJECTIVE: To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classified as: normal, 0.91–1.3; low, ≤0.9; high, >1.3; or noncompressible artery (NC). Baseline characteristics were examined according to ABI and by multivariate analysis. RESULTS: ABI was normal in 66%, low in 19%, and high in 8% of patients, and 6% of patients had NC. Of the low ABI patients, 68% were asymptomatic. Using normal ABI as referent, low ABI was independently associated with smoking, female sex, black race, hypertension, age, C-reactive protein, diabetes duration, and lower BMI. High ABI was associated with male sex, nonblack race, and higher BMI; and NC artery was associated with diabetes duration, higher BMI, and hypertension. CONCLUSIONS: ABI abnormalities are common and often asymptomatic in patients with type 2 diabetes and CAD.
format Text
id pubmed-3024368
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-30243682012-02-01 The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Singh, Premranjan P. Abbott, J. Dawn Lombardero, Manuel S. Sutton-Tyrrell, Kim Woodhead, Gail Venkitachalam, Lakshmi Tsapatsaris, Nicholas P. Piemonte, Thomas C. Lago, Rodrigo M. Rutter, Martin K. Nesto, Richard W. Diabetes Care Original Research OBJECTIVE: To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classified as: normal, 0.91–1.3; low, ≤0.9; high, >1.3; or noncompressible artery (NC). Baseline characteristics were examined according to ABI and by multivariate analysis. RESULTS: ABI was normal in 66%, low in 19%, and high in 8% of patients, and 6% of patients had NC. Of the low ABI patients, 68% were asymptomatic. Using normal ABI as referent, low ABI was independently associated with smoking, female sex, black race, hypertension, age, C-reactive protein, diabetes duration, and lower BMI. High ABI was associated with male sex, nonblack race, and higher BMI; and NC artery was associated with diabetes duration, higher BMI, and hypertension. CONCLUSIONS: ABI abnormalities are common and often asymptomatic in patients with type 2 diabetes and CAD. American Diabetes Association 2011-02 2011-01-20 /pmc/articles/PMC3024368/ /pubmed/21270200 http://dx.doi.org/10.2337/dc10-1734 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Singh, Premranjan P.
Abbott, J. Dawn
Lombardero, Manuel S.
Sutton-Tyrrell, Kim
Woodhead, Gail
Venkitachalam, Lakshmi
Tsapatsaris, Nicholas P.
Piemonte, Thomas C.
Lago, Rodrigo M.
Rutter, Martin K.
Nesto, Richard W.
The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
title The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
title_full The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
title_fullStr The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
title_full_unstemmed The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
title_short The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
title_sort prevalence and predictors of an abnormal ankle-brachial index in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024368/
https://www.ncbi.nlm.nih.gov/pubmed/21270200
http://dx.doi.org/10.2337/dc10-1734
work_keys_str_mv AT singhpremranjanp theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT abbottjdawn theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT lombarderomanuels theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT suttontyrrellkim theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT woodheadgail theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT venkitachalamlakshmi theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT tsapatsarisnicholasp theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT piemontethomasc theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT lagorodrigom theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT ruttermartink theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT nestorichardw theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT singhpremranjanp prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT abbottjdawn prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT lombarderomanuels prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT suttontyrrellkim prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT woodheadgail prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT venkitachalamlakshmi prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT tsapatsarisnicholasp prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT piemontethomasc prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT lagorodrigom prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT ruttermartink prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT nestorichardw prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial
AT prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial